c-Jun N-terminal kinase and Akt signalling pathways regulating tumour necrosis factor-α-induced interleukin-32 expression in human lung fibroblasts: Implications in airway inflammation

Immunology

Volumn 144, Issue 2, 2015, Pages 282-290

  Li, Dagen ^a   Chen, Dapeng ^a   Zhang, Xuemei ^a   Wang, Hong ^a   Song, Zixin ^a   Xu, Wenchun ^a   He, Yujuan ^a   Yin, Yibing ^a   Cao, Ju ^b  

^a CHONGQING MEDICAL UNIVERSITY   (China)

^b THE FIRST AFFILIATED HOSPITAL OF CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

Cytokines; Fibroblasts; Inflammation

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 17; INTERLEUKIN 27; INTERLEUKIN 32; INTERLEUKIN 32ALPHA; INTERLEUKIN 32BETA; INTERLEUKIN 32DELTA; INTERLEUKIN 32GAMMA; INTERLEUKIN 4; LIGAND; MESSENGER RNA; PROTEIN KINASE B; STRESS ACTIVATED PROTEIN KINASE; TOLL LIKE RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; IL17A PROTEIN, HUMAN; IL27 PROTEIN, HUMAN; IL32 PROTEIN, HUMAN; IL4 PROTEIN, HUMAN; INTERLEUKIN DERIVATIVE; ISOPROTEIN; RECOMBINANT PROTEIN;

ARTICLE; ASTHMA; CHRONIC OBSTRUCTIVE LUNG DISEASE; CYTOKINE PRODUCTION; CYTOKINE RELEASE; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; IMMUNOREGULATION; LUNG FIBROBLAST; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RESPIRATORY TRACT INFLAMMATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; UPREGULATION; WESTERN BLOTTING; ANTAGONISTS AND INHIBITORS; BIOSYNTHESIS; CELL CULTURE; CYTOLOGY; FIBROBLAST; GENETICS; IMMUNOLOGY; INFLAMMATION; LUNG; METABOLISM;

ASTHMA; CELLS, CULTURED; FIBROBLASTS; HUMANS; INFLAMMATION; INTERFERON-GAMMA; INTERLEUKIN-17; INTERLEUKIN-4; INTERLEUKINS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; LUNG; PROTEIN ISOFORMS; PROTO-ONCOGENE PROTEINS C-AKT; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RECOMBINANT PROTEINS; RNA, MESSENGER; TOLL-LIKE RECEPTORS; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 84922552705     PISSN: 00192805     EISSN: 13652567     Source Type: Journal    
DOI: 10.1111/imm.12374     Document Type: Article

References (42)

1. Hallstrand TS, Hackett TL, Altemeier WA, Matute-Bello G, Hansbro PM, Knight DA. Airway epithelial regulation of pulmonary immune homeostasis and inflammation. Clin Immunol 2014; 151:1-15.
2. Grainge CL, Davies DE. Epithelial injury and repair in airways diseases. Chest 2013; 144:1906-12.
3. Brusselle GG, Provoost S, Bracke KR, Kuchmiy A, Lamkanfi M. Inflammasomes in respiratory disease: from bench to bedside. Chest 2014; 145:1121-33.
4. Rezaee F, Georas SN. Breaking barriers. New insights into airway epithelial barrier function in health and disease. Am J Respir Cell Mol Biol 2014; 50:857-69.
5. Schuijs MJ, Willart MA, Hammad H, Lambrecht BN. Cytokine targets in airway inflammation. Curr Opin Pharmacol 2013; 13:351-61.
6. Koltsida O, Karamnov S, Pyrillou K et al. Toll-like receptor 7 stimulates production of specialized pro-resolving lipid mediators and promotes resolution of airway inflammation. EMBO Mol Med 2013; 5:762-75.
7. Bazzan E, Saetta M, Turato G et al. Expression of the atypical chemokine receptor D6 in human alveolar macrophages in COPD. Chest 2013; 143:98-106.
8. Joosten LA, Heinhuis B, Netea MG, Dinarello CA. Novel insights into the biology of interleukin-32. Cell Mol Life Sci 2013; 70:3883-92.
9. Li W, Sun W, Liu L et al. IL-32: a host proinflammatory factor against influenza viral replication is upregulated by aberrant epigenetic modifications during influenza A virus infection. J Immunol 2010; 185:5056-65.
10. Lee S, Kim JH, Kim H et al. Activation of the interleukin-32 pro-inflammatory pathway in response to human papillomavirus infection and over-expression of interleukin-32 controls the expression of the human papillomavirus oncogene. Immunology 2011; 132:410-20.
11. Nold-Petry CA, Nold MF, Zepp JA, Kim SH, Voelkel NF, Dinarello CA. IL-32-dependent effects of IL-1β on endothelial cell functions. Proc Natl Acad Sci U S A 2009; 106:3883-8.
12. Calabrese F, Baraldo S, Bazzan E et al. IL-32, a novel proinflammatory cytokine in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2008; 178:894-901.
13. Meyer N, Christoph J, Makrinioti H et al. Inhibition of angiogenesis by IL-32: possible role in asthma. J Allergy Clin Immunol 2012; 129:964-73.
14. Arcaroli JJ, Liu N, Yi N, Abraham E. Association between IL-32 genotypes and outcome in infection-associated acute lung injury. Crit Care 2011; 15:R138.
15. Dreymueller D, Martin C, Kogel T, Pruessmeyer J, Hess FM, Horiuchi K, Uhlig S, Ludwig A. Lung endothelial ADAM17 regulates the acute inflammatory response to lipopolysaccharide. EMBO Mol Med 2012; 4:412-23.
16. Dong S, Zhang X, He Y et al. Synergy of IL-27 and TNF-α in regulating CXCL10 expression in lung fibroblasts. Am J Respir Cell Mol Biol 2013; 48:518-30.
17. Bang BR, Kwon HS, Kim SH et al. Interleukin-32γ suppresses allergic airway inflammation in mouse models of asthma. Am J Respir Cell Mol Biol 2014; 50:1021-30.
18. Cao J, Wong CK, Yin Y, Lam CW. Activation of human bronchial epithelial cells by inflammatory cytokines IL-27 and TNF-α: implications for immunopathophysiology of airway inflammation. J Cell Physiol 2010; 223:788-97.
19. Cao J, Zhang L, Li D, Xu F, Huang S, Xiang Y, Yin Y, Ren G. IL-27 is elevated in patients with COPD and patients with pulmonary TB and induces human bronchial epithelial cells to produce CXCL10. Chest 2012; 141:121-30.
20. Schwarze J, Mackenzie KJ. Novel insights into immune and inflammatory responses to respiratory viruses. Thorax 2013; 68:108-10.
21. Andrews AL, Nasir T, Bucchieri F, Holloway JW, Holgate ST, Davies DE. IL-13 receptor α2: a regulator of IL-13 and IL-4 signal transduction in primary human fibroblasts. J Allergy Clin Immunol 2006; 118:858-65.
22. Zeng Q, Li S, Zhou Y et al. Interleukin-32 contributes to invasion and metastasis of primary lung adenocarcinoma via NF-κB induced matrix metalloproteinases 2 and 9 expression. Cytokine 2014; 65:24-32.
23. Netea MG, Azam T, Ferwerda G et al. IL-32 synergizes with nucleotide oligomerization domain (NOD) 1 and NOD2 ligands for IL-1β and IL-6 production through a caspase 1-dependent mechanism. Proc Natl Acad Sci U S A 2005; 102:16309-14.
24. Kobayashi H, Huang J, Ye F, Shyr Y, Blackwell TS, Lin PC. Interleukin-32β propagates vascular inflammation and exacerbates sepsis in a mouse model. PLoS One 2010; 5:e9458.
25. Nold-Petry CA, Rudloff I, Baumer Y et al. IL-32 promotes angiogenesis. J Immunol 2014; 192:589-602.
26. Netea MG, Azam T, Lewis EC et al. Mycobacterium tuberculosis induces interleukin-32 production through a caspase- 1/IL-18/interferon-γ-dependent mechanism. PLoS Med 2006; 3:e277.
27. Keswani A, Chustz RT, Suh L et al. Differential expression of interleukin-32 in chronic rhinosinusitis with and without nasal polyps. Allergy 2012; 67:25-32.
28. Meyer N, Zimmermann M, Bürgler S et al. IL-32 is expressed by human primary keratinocytes and modulates keratinocyte apoptosis in atopic dermatitis. J Allergy Clin Immunol 2010; 125:858-65.
29. Alsaleh G, Sparsa L, Chatelus E, Ehlinger M, Gottenberg JE, Wachsmann D, Sibilia J. Innate immunity triggers IL-32 expression by fibroblast-like synoviocytes in rheumatoid arthritis. Arthritis Res Ther 2010; 12:R135.
30. Goda C1, Kanaji T, Kanaji S, Tanaka G, Arima K, Ohno S, Izuhara K. Involvement of IL-32 in activation-induced cell death in T cells. Int Immunol 2006; 18:233-40.
31. Li W, Yang F, Liu Y et al. Negative feedback regulation of IL-32 production by iNOS activation in response to dsRNA or influenza virus infection. Eur J Immunol 2009; 39:1019-24.
32. Nakayama M, Niki Y, Kawasaki T, Takeda Y, Ikegami H, Toyama Y, Miyamoto T. IL-32-PAR2 axis is an innate immunity sensor providing alternative signaling for LPS-TRIF axis. Sci Rep 2013; 3:2960.
33. Selleri S, Palazzo M, Deola S, Wang E, Balsari A, Marincola FM, Rumio C. Induction of pro-inflammatory programs in enteroendocrine cells by the Toll-like receptor agonists flagellin and bacterial LPS. Int Immunol 2008; 20:961-70.
34. Turner-Brannen E, Choi KY, Arsenault R, El-Gabalawy H, Napper S, Mookherjee N. Inflammatory cytokines IL-32 and IL-17 have common signaling intermediates despite differential dependence on TNF-receptor 1. J Immunol 2011; 186:7127-35.
35. Mun SH, Kim JW, Nah SS et al. Tumor necrosis factor α-induced interleukin-32 is positively regulated via the Syk/protein kinase Cδ/JNK pathway in rheumatoid synovial fibroblasts. Arthritis Rheum 2009; 60:678-85.
36. Bai X, Ovrutsky AR, Kartalija M et al. IL-32 expression in the airway epithelial cells of patients with Mycobacterium avium complex lung disease. Int Immunol 2011; 23:679-91.
37. Soler N, Ewig S, Torres A, Filella X, Gonzalez J, Zaubet A. Airway inflammation and bronchial microbial patterns in patients with stable chronic obstructive pulmonary disease. Eur Respir J 1999; 14:1015-22.
38. Wong CK, Ho CY, Ko FW, Chan CH, Ho AS, Hui DS, Lam CW. Proinflammatory cytokines (IL-17, IL-6, IL-18 and IL-12) and Th cytokines (IFN-γ, IL-4, IL-10 and IL-13) in patients with allergic asthma. Clin Exp Immunol 2001; 125:177-83.
39. Shannon J, Ernst P, Yamauchi Y et al. Differences in airway cytokine profile in severe asthma compared to moderate asthma. Chest 2008; 133:420-6.
40. Barceló B, Pons J, Fuster A, Sauleda J, Noguera A, Ferrer JM, Agustí AG. Intracellular cytokine profile of T lymphocytes in patients with chronic obstructive pulmonary disease. Clin Exp Immunol 2006; 145:474-9.
41. Eustace A1, Smyth LJ, Mitchell L, Williamson K, Plumb J, Singh D. Identification of cells expressing IL-17A and IL-17F in the lungs of patients with COPD. Chest 2011; 139:1089-100.
42. Kawaguchi M, Kokubu F, Kuga H et al. Modulation of bronchial epithelial cells by IL-17. J Allergy Clin Immunol 2001; 108:804-9.